Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF | V.TLT.W

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Single most important change

<< Previous

Bullboard Posts

Next >>

Comment by skier59on Aug 30, 2022 8:46am

168 Views

Post# 34929034

RE:Single most important change

Hum YA !!!!!.....

DJDawg wrote:
The biggest change that I can see is the way the 360 patient CR has gone up
Because it seems from previous data that all patients who make it to 360 CR keep it at 450. Recall that the previous 360 was 5 patients, followed by 5 at 450.

Now we have 9 patients at 360 (35% of 26) there is quite a good chance that those 4 new CR patients will flow into 450 day totals. Those will bump up the 450 day percent quite nicely.

Other comments:
- the last few days we have witnessed a lot of swings. Whether from nervous people thinking that the numbers are not going to support the stock or from people playing the swing trade game. Since all those people follow the stock, my prediction is that many will try to swing back in. Since the longholders are not selling, I wonder if there will be a rally.
- Dr. Vera leaving is interesting and confusing. The thing that keeps me grounded is that the data all has to go through the lead medical investigators. The data cannot be manipulated by someone at TLT. Given the science behind Dr. Macfarland's work and the amazing phase 1 b patients (1 and done cure in two patient) I know that there is no shadyness behind the science. Having read reviews by people who worked at the company it doesn't sound that fun to work there. Just what is there in other forums. I do think it is possible that the work environment for TLT is not great.

All in all I continue to have great confidence in the science and middling confidence in the company itself. I think the science will get us to to the finish line no matter how many time wasting/money wasting lawsuits are launched.